India's Natco Pharma ties up with Gilead on hepatitis C drugs

Indian generic drugmaker Natco Pharma Ltd said it has agreed a deal with Gilead Sciences Inc to supply generic copies of the U.S. drugmaker's chronic hepatitis C medicines, including $1,000-a-pill drug Sovaldi, in 91 developing nations.

http://in.reuters.com/article/2015/03/02/natco-pharma-gilead-sciences-deals-idINKBN0LY0G120150302

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING